PhD position ‚Pharmacological immune modulation‘ (m/f)

Our research group at the Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, is looking for a PhD student.

The project deals with the function of HCA2 as a drug target. At the interface of metabolism and the immune system, activation of HCA2 has effects on various tissues and cell types in the body (J Clin Invest 2014, 124: 2188-2192; Nat Commun 2014, 5: 3944; Trends Mol Med 2015, 21: 245-255; Front Immunol 2018, 9: 1890). Now we would like to dissect the role of potential target cells.

We are looking for an enthusiastic scientist who holds a degree in biology, biochemistry, medicine, or related subjects. A background in molecular biology or translational research would be helpful.

The salary will be paid according TV-L, E13.

Weekly working time is 65 %.

The position is initially limited for 3 years.

The University of Lübeck seeks for a balance between male and female employees. Therefore women with the same suitability, ability and technical achievement will be hired preferred. The university also strives for the employment of severly handicapped persons. Severly handicapped persons will be preferred for the same qualification set.

For questions please contact Prof. Dr. Markus Schwaninger, Institute for Experimental and Clinical Pharmacology and Toxycology, University of Lübeck, Ratzeburger Allee 160, D-23562 Lübeck, E-Mail: markus.schwaninger@pharma.uni-luebeck.de.

For more information: https://www.uksh.de/pharma-luebeck/.